Go Pro

Pixelworks (PXLW) Competitors

Pixelworks logo
$7.14 +0.26 (+3.78%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$7.12 -0.02 (-0.28%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PXLW vs. RDCM, ZSQR, EGAN, TRAK, and RAAS

Should you buy Pixelworks stock or one of its competitors? Pixelworks's main competitors and comparable companies include Radcom (RDCM), Coeptis Therapeutics (ZSQR), eGain (EGAN), ReposiTrak (TRAK), and Cloopen Group (RAAS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Pixelworks compare to Radcom?

Radcom (NASDAQ:RDCM) and Pixelworks (NASDAQ:PXLW) are both small-cap technology companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership.

Radcom presently has a consensus price target of $14.00, indicating a potential upside of 41.27%. Pixelworks has a consensus price target of $16.00, indicating a potential upside of 124.09%. Given Pixelworks' stronger consensus rating and higher possible upside, analysts clearly believe Pixelworks is more favorable than Radcom.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Radcom
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Pixelworks
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Radcom has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market. Comparatively, Pixelworks has a beta of 1.52, meaning that its share price is 52% more volatile than the broader market.

Radcom has a net margin of 10.47% compared to Pixelworks' net margin of 0.00%. Radcom's return on equity of 6.51% beat Pixelworks' return on equity.

Company Net Margins Return on Equity Return on Assets
Radcom10.47% 6.51% 5.17%
Pixelworks N/A -28.77%-14.64%

In the previous week, Radcom had 2 more articles in the media than Pixelworks. MarketBeat recorded 4 mentions for Radcom and 2 mentions for Pixelworks. Pixelworks' average media sentiment score of 0.96 beat Radcom's score of 0.78 indicating that Pixelworks is being referred to more favorably in the news media.

Company Overall Sentiment
Radcom Positive
Pixelworks Positive

48.3% of Radcom shares are held by institutional investors. Comparatively, 21.4% of Pixelworks shares are held by institutional investors. 69.0% of Radcom shares are held by insiders. Comparatively, 4.7% of Pixelworks shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Radcom has higher revenue and earnings than Pixelworks. Pixelworks is trading at a lower price-to-earnings ratio than Radcom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Radcom$71.49M2.32$11.99M$0.4223.60
Pixelworks$690K62.60-$22.50M-$1.63N/A

Summary

Radcom beats Pixelworks on 10 of the 16 factors compared between the two stocks.

How does Pixelworks compare to Coeptis Therapeutics?

Coeptis Therapeutics (NASDAQ:ZSQR) and Pixelworks (NASDAQ:PXLW) are both small-cap technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Pixelworks has a net margin of 0.00% compared to Coeptis Therapeutics' net margin of -773.72%. Pixelworks' return on equity of -28.77% beat Coeptis Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Coeptis Therapeutics-773.72% -49.45% -46.88%
Pixelworks N/A -28.77%-14.64%

In the previous week, Coeptis Therapeutics had 2 more articles in the media than Pixelworks. MarketBeat recorded 4 mentions for Coeptis Therapeutics and 2 mentions for Pixelworks. Pixelworks' average media sentiment score of 0.96 beat Coeptis Therapeutics' score of 0.83 indicating that Pixelworks is being referred to more favorably in the news media.

Company Overall Sentiment
Coeptis Therapeutics Positive
Pixelworks Positive

Coeptis Therapeutics has a beta of -0.25, suggesting that its share price is 125% less volatile than the broader market. Comparatively, Pixelworks has a beta of 1.52, suggesting that its share price is 52% more volatile than the broader market.

Coeptis Therapeutics has higher revenue and earnings than Pixelworks. Pixelworks is trading at a lower price-to-earnings ratio than Coeptis Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Coeptis Therapeutics$1.36M119.64-$11.92M-$1.63N/A
Pixelworks$690K62.60-$22.50M-$1.63N/A

13.9% of Coeptis Therapeutics shares are owned by institutional investors. Comparatively, 21.4% of Pixelworks shares are owned by institutional investors. 24.3% of Coeptis Therapeutics shares are owned by company insiders. Comparatively, 4.7% of Pixelworks shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Pixelworks has a consensus target price of $16.00, indicating a potential upside of 124.09%. Given Pixelworks' stronger consensus rating and higher probable upside, analysts plainly believe Pixelworks is more favorable than Coeptis Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Coeptis Therapeutics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Pixelworks
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Pixelworks beats Coeptis Therapeutics on 9 of the 15 factors compared between the two stocks.

How does Pixelworks compare to eGain?

Pixelworks (NASDAQ:PXLW) and eGain (NASDAQ:EGAN) are both small-cap technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

eGain has higher revenue and earnings than Pixelworks. Pixelworks is trading at a lower price-to-earnings ratio than eGain, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pixelworks$690K62.60-$22.50M-$1.63N/A
eGain$91.14M1.58$8.88M$0.3216.44

21.4% of Pixelworks shares are held by institutional investors. Comparatively, 53.9% of eGain shares are held by institutional investors. 4.7% of Pixelworks shares are held by insiders. Comparatively, 38.7% of eGain shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

eGain has a net margin of 9.74% compared to Pixelworks' net margin of 0.00%. eGain's return on equity of 11.63% beat Pixelworks' return on equity.

Company Net Margins Return on Equity Return on Assets
PixelworksN/A -28.77% -14.64%
eGain 9.74%11.63%7.12%

In the previous week, eGain had 5 more articles in the media than Pixelworks. MarketBeat recorded 7 mentions for eGain and 2 mentions for Pixelworks. Pixelworks' average media sentiment score of 0.96 beat eGain's score of 0.49 indicating that Pixelworks is being referred to more favorably in the media.

Company Overall Sentiment
Pixelworks Positive
eGain Neutral

Pixelworks currently has a consensus target price of $16.00, suggesting a potential upside of 124.09%. eGain has a consensus target price of $6.50, suggesting a potential upside of 23.57%. Given Pixelworks' stronger consensus rating and higher possible upside, equities analysts plainly believe Pixelworks is more favorable than eGain.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pixelworks
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
eGain
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Pixelworks has a beta of 1.52, suggesting that its stock price is 52% more volatile than the broader market. Comparatively, eGain has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

Summary

eGain beats Pixelworks on 10 of the 16 factors compared between the two stocks.

How does Pixelworks compare to ReposiTrak?

ReposiTrak (NYSE:TRAK) and Pixelworks (NASDAQ:PXLW) are both small-cap technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

In the previous week, ReposiTrak had 1 more articles in the media than Pixelworks. MarketBeat recorded 3 mentions for ReposiTrak and 2 mentions for Pixelworks. Pixelworks' average media sentiment score of 0.96 beat ReposiTrak's score of 0.56 indicating that Pixelworks is being referred to more favorably in the news media.

Company Overall Sentiment
ReposiTrak Positive
Pixelworks Positive

ReposiTrak has a net margin of 30.75% compared to Pixelworks' net margin of 0.00%. ReposiTrak's return on equity of 14.44% beat Pixelworks' return on equity.

Company Net Margins Return on Equity Return on Assets
ReposiTrak30.75% 14.44% 12.85%
Pixelworks N/A -28.77%-14.64%

Pixelworks has a consensus target price of $16.00, suggesting a potential upside of 124.09%. Given Pixelworks' stronger consensus rating and higher probable upside, analysts plainly believe Pixelworks is more favorable than ReposiTrak.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ReposiTrak
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Pixelworks
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

27.4% of ReposiTrak shares are held by institutional investors. Comparatively, 21.4% of Pixelworks shares are held by institutional investors. 41.0% of ReposiTrak shares are held by insiders. Comparatively, 4.7% of Pixelworks shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

ReposiTrak has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Pixelworks has a beta of 1.52, meaning that its share price is 52% more volatile than the broader market.

ReposiTrak has higher revenue and earnings than Pixelworks. Pixelworks is trading at a lower price-to-earnings ratio than ReposiTrak, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ReposiTrak$22.61M6.43$6.98M$0.3721.62
Pixelworks$690K62.60-$22.50M-$1.63N/A

Summary

ReposiTrak beats Pixelworks on 10 of the 16 factors compared between the two stocks.

How does Pixelworks compare to Cloopen Group?

Pixelworks (NASDAQ:PXLW) and Cloopen Group (NYSE:RAAS) are both technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

Pixelworks currently has a consensus target price of $16.00, indicating a potential upside of 124.09%. Given Pixelworks' stronger consensus rating and higher probable upside, research analysts clearly believe Pixelworks is more favorable than Cloopen Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pixelworks
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Cloopen Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Pixelworks has higher earnings, but lower revenue than Cloopen Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pixelworks$690K62.60-$22.50M-$1.63N/A
Cloopen Group$76.61M1.85-$34.23MN/AN/A

21.4% of Pixelworks shares are held by institutional investors. 4.7% of Pixelworks shares are held by company insiders. Comparatively, 9.8% of Cloopen Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Pixelworks had 2 more articles in the media than Cloopen Group. MarketBeat recorded 2 mentions for Pixelworks and 0 mentions for Cloopen Group. Pixelworks' average media sentiment score of 0.96 beat Cloopen Group's score of 0.00 indicating that Pixelworks is being referred to more favorably in the media.

Company Overall Sentiment
Pixelworks Positive
Cloopen Group Neutral

Cloopen Group's return on equity of 0.00% beat Pixelworks' return on equity.

Company Net Margins Return on Equity Return on Assets
PixelworksN/A -28.77% -14.64%
Cloopen Group N/A N/A N/A

Summary

Pixelworks beats Cloopen Group on 8 of the 12 factors compared between the two stocks.

Get Pixelworks News Delivered to You Automatically

Sign up to receive the latest news and ratings for PXLW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PXLW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PXLW vs. The Competition

MetricPixelworksSoftware IndustryTechnology SectorNASDAQ Exchange
Market Cap$43.19M$15.47B$30.13B$12.85B
Dividend YieldN/A3.43%2.74%11.71%
P/E Ratio-4.38123.7568.5320.80
Price / Sales62.601,289.44592.4990.54
Price / CashN/A44.8447.9151.52
Price / Book24.628.347.706.20
Net Income-$22.50M$434.47M$704.99M$358.50M
7 Day Performance0.28%-2.04%-1.08%-2.35%
1 Month Performance7.37%-1.09%-3.65%-2.77%
1 Year Performance-38.40%-0.19%180.35%7.63%

Pixelworks Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PXLW
Pixelworks
2.9181 of 5 stars
$7.14
+3.8%
$16.00
+124.1%
-42.7%$43.19M$690KN/A220
RDCM
Radcom
3.1828 of 5 stars
$9.92
-1.1%
$14.00
+41.1%
-31.0%$166.06M$71.49M23.62280
ZSQR
Coeptis Therapeutics
0.4196 of 5 stars
$3.09
+4.7%
N/A-75.3%$163.77M$1.36MN/A2
EGAN
eGain
2.2417 of 5 stars
$5.21
-10.8%
$13.00
+149.5%
-35.0%$143.01M$91.14M16.28690
TRAK
ReposiTrak
0.6089 of 5 stars
$7.83
-1.1%
N/A-53.3%$142.30M$23.47M21.1670

Related Companies and Tools


This page (NASDAQ:PXLW) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners